Home Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
Article Open Access

Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth

  • Yu Long , Zengchun Hu , Dian Yang , Fuqiang Wang , Chen’ge Zhao , Yang Zhang , Yingqiu Zhang , Hui Ma EMAIL logo and Huiyi Lv EMAIL logo
Published/Copyright: February 9, 2023

Abstract

Glioblastoma (GBM) is a malignant brain tumor. The purpose of this study is to estimate the potential effects and underlying mechanisms of a ubiquitin-specific protease 8 (USP8) small-molecule inhibitor on the phenotypic characteristics of GBM cells. The growth, migration, invasion, and stemness of GBM LN229 and T98G cells were evaluated by conducting cell proliferation, colony formation, wound healing, transwell, Ki-67 staining, spheroid formation, and ionizing radiation assays, and the results collectively showed the suppressive effects of USP8 inhibition on GBM cells. Furthermore, transcriptomic profiling of GBM cells treated with the USP8 inhibitor deubiquitinase (DUB)-IN-1 revealed significantly altered mRNA expression induced by pharmacological USP8 inhibition, from which we confirmed downregulated Aurora kinase A (AURKA) protein levels using immunoblotting assays. Our findings indicated that the proliferation, invasion, and stemness of LN229 and T98G cells were markedly suppressed by USP8 inhibition. Pharmacological USP8 suppression elicits multiple tumor-inhibitory effects, likely through dysregulating various mRNA expression events, including that of the key cell cycle regulator and oncogenic protein AURKA. Therefore, our observations corroborate the GBM-supportive roles of USP8 and suggest pharmacological USP8 inhibition is a viable therapeutic approach to target GBM. The purpose of this study was to investigate the effect and mechanism of action of the USP8 inhibitor DUB-IN-1 on GBM.

1 Introduction

Glioblastoma (GBM) is a high-grade subtype of malignant glioma that is categorized as grade IV astrocytoma by the World Health Organization and is often associated with an unfavorable prognosis [1]. Despite advances in the development of multiple therapies against this malignancy, clinical outcomes of patients with GBM have remained unsatisfactory [2,3]. Currently, maximum protection surgical resection, adjuvant radiotherapy, and chemotherapy are the major therapeutic modalities in the clinical management of patients with GBM. Therefore, further investigation on GBM is urgently needed to identify potential therapeutic targets for the development of predictive biomarkers and effective therapies [4].

Regulated protein degradation has been established as a vital controlling factor during tumorigenesis, with related oncogenic proteins considered potential therapeutic targets in the treatment of many cancers [5,6]. Protein ubiquitination is the dominant post-translational modification that mediates protein degradation [7] and involves a wide range of cellular activities, such as apoptosis and cell survival. Protein ubiquitination is a reversible process of post-translational modification, with deubiquitinases (DUBs) catalyzing the release of ubiquitin molecules covalently bound to substrates [8]. Therefore, the deubiquitinase activity of DUBs can counteract the proteasomal or lysosomal degradation of ubiquitinated protein substrates [9]. Ubiquitin-specific proteases (USPs) are the biggest family of DUBs [7], and several members of the USP family have been reported to participate in the initiation and development of human malignancies including GBM.

Ubiquitin-specific protease 8 (USP8), also referred to as UBPY [10], is a deubiquitinating enzyme implicated in tumorigenesis of multiple cancer types, including breast cancer [11] and glioma [12]. Therefore, USP8 has become increasingly considered as a potential anti-cancer therapeutic target. In 2010, DUB-IN-1 (compound 22 d) and a series of its analogs (compounds 22 b–f) were synthesized by Colombo et al. [13], all of which were reported to be potent inhibitors of USP8 deubiquitinating activity. DUB-IN-1 and its analogs inhibited the growth of colon and prostate cancer cells, with IC50s ranging 0.5–1.5 µM. Novel USP8 inhibitors were further discovered and exhibited anticancer efficiency, and treatment with the USP8 inhibitor or siRNA targeting USP8 was reported to inhibit HER-3-positive gastric cancer cell growth [14]. Previous studies have shown that the USP8 inhibitor DUBs-IN-2 effectively inhibited the growth of breast cancer cells [11]. In the current study, we evaluated the influence of the USP8 inhibitor, DUB-IN-1, on the phenotypic features of GBM cells in vitro. Our findings showed that the pharmacological inhibition of USP8 effectively hindered the proliferation, invasion, and stemness of GBM cells. Transcriptomic profiling of GBM cells treated with the USP8 inhibitor DUB-IN-1 revealed altered expression of multiple genes implicated in tumorigenesis, including the key cell cycle regulator Aurora kinase A (AURKA). Therefore, our results corroborate the oncogenic properties of USP8 in GBM tumorigenesis and advocate it as an achievable anti-cancer target for future development.

2 Materials and methods

2.1 Cell culture

Human GBM T98G, LN229, and U87MG cell lines were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA). LN229 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, USA). U87MG and T98G cells were cultured in Eagle’s Minimum Essential Medium (EMEM; Gibco, USA). All cells were cultured in medium supplemented with 10% fetal bovine serum (FBS; Excel, China) and 1% penicillin/streptomycin (Thermo Fisher Scientific, USA) with 5% CO2 at 37℃.

2.2 Antibodies and reagents

The antibodies used were mouse anti-GAPDH antibody (Proteintech, 60004-1, 1:5,000, China), mouse anti-Ki-67 antibody (BD Biosciences, 558616, 1:100, USA), and mouse anti-AURKA antibody (Abcam, ab13824, 1:4,000, USA). USP8 inhibitor DUB-IN-1 was purchased from MedChemExpress (MCE, HY-50736, USA).

2.3 Cell viability assay

GBM cell proliferation was determined using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay, as previously described [15]. LN229, U87MG, and T98G cells (4 × 103 of each) were seeded in 96-well plates with 200 µL of medium. The following day, the cells were treated with the USP8 inhibitor DUB-IN-1 or dimethylsulfoxide (DMSO) as a control at various concentrations. Twenty microliters of MTT solution (5 mg/mL) were added to each well to detect cell proliferation after 24 and 48 h of culture, and then, the plates were incubated for 2–4 h at 37°C. The medium was removed, and 150 µL of DMSO (Solarbio, China) was added to each well to dissolve formazan with shaking for 15 min. Absorbance was measured using a spectrometer at 570 and 630 nm.

2.4 Colony formation assay

Seeding densities of 1,500 cells/well (T98G) and 2,000 cells/well (LN229) were seeded in six-well plates as previously described [16]. Cells were treated with the USP8 inhibitor DUB-IN-1 or DMSO as a control, and drugs were replenished every 36 h. After 2 weeks of culture, the cells were fixed with methanol (Kermal, China) for 15 min and stained with 0.1% crystal violet for 15 min. The cell colonies were imaged with ChemiDoc XRS + and quantified using ImageJ software.

2.5 Ionizing radiation (IR) assay

Seeding densities of 1,500 cells/well (T98G) and 2,000 cells/well (LN229) were seeded in six-well plates as previously described. The following day, cells were treated with the USP8 inhibitor DUB-IN-1 or DMSO as a control and irradiated using an X-RAD 320ix Biological Irradiator (Precision X-ray Inc.) at doses of 2, 4, and 6 Gy in 2 h. The inhibitor was refreshed every 3 d. After 2 weeks of culture, the cells were fixed with methanol (Kermal, China) for 15 min and stained with 0.1% crystal violet for 15 min. The cell colonies were imaged using ChemiDoc XRS + and quantified with the ImageJ software.

2.6 Transwell assay

Cell migration and invasion were detected using Transwell chambers (8 µm pore size, Costar). Seeding densities of 4 × 104 cells (LN229 and T98G) were seeded into the upper chamber after treatment with the USP8 inhibitor DUB-IN-1 or DMSO as a control, and the lower chambers contained 500 µL medium with FBS. Following incubation for 24 h at 37°C, the migrated cells were fixed with methanol for 15 min and stained with 0.1% crystal violet for 15 min. The cells were imaged using an inverted microscope (Leica, Germany) and quantified using ImageJ software.

2.7 Ki-67 staining assay

The cells were then cultured on sterilized glass coverslips. After treatment with the USP8 inhibitor DUB-IN-1 or DMSO as a control for 24 h, the cells were fixed in 4% paraformaldehyde for 15 min, treated with 0.2% Triton X100 for 5 min, blocked in 2% bovine serum albumin (BSA) for 30 min, incubated with anti-Ki-67 antibody for 30 min, and then incubated with the secondary antibody for 45 min. Coverslips were then mounted on glass slides with 10 µL of Mowiol supplemented with 4′,6-diamidino-2-phenylindole I (DAP; Life Technologies, USA). Using a fluorescent microscope (Leica, Germany) to capture the images, Ki-67 expression was quantified using ImageJ software.

2.8 Cell lysis and immunoblotting

Immunoblotting procedures were followed as previously described [17]. After treatment of LN229 and T98G cells with the USP8 inhibitor DUB-IN-1 or DMSO as a control for 24 h, cells were treated with radio immunoprecipitation assay buffer (10 mM Tris–HCl pH 7.5, 1% w/v Triton X-100, 150 mM NaCl, 1% sodium deoxycholate, and 0.1% w/v sodium dodecyl-sulfate [SDS]), centrifuged at 15,000 rpm for 20 min, and analyzed using a Coomassie protein assay kit. The total protein sample were separated using 10% SDS-polyacrylamide gel electrophoresis and then transferred to nitrocellulose membranes (Merck Millipore, USA), blocked with 4% fat-free milk 1 hour at room temperature, and then incubated overnight with the primary antibody at 4℃. The blots were then incubated with secondary antibodies for 1 hour and scanned using a LICOR Odyssey system. Image Studio (version 4.0) software was used to analyze the images.

2.9 Spheroid formation assay

A spheroid formation assay was conducted as previously described [18]. Seeding densities of 500 cells/well (T98G and LN229) were seeded in 96-well plates (ultra-low attachment) in the serum-free DMEM-F12 medium supplemented with B27 (2% v/v), basic fibroblast growth factor (20 ng/mL), epidermal growth factor (20 ng/ml), and 1% penicillin/streptomycin. After treatment with the USP8 inhibitor DUB-IN-1 or DMSO as a control for 3 d, the USP8 inhibitor DUB-IN-1 and DMEM-F12 medium were added every two d. After 2 weeks, the images were captured using a phase-contrast microscope (Leica, Germany) on days 7 and 14. The spheroid sizes were quantified using Photoshop (version 2019) software.

2.10 Wound healing assay

A 200 µL pipette tip was used to create a wound in a confluent monolayer of cells, as previously described [19]. The cells were cultured in a medium without FBS and treated with the USP8 inhibitor DUB-IN-1 or DMSO as a control. Cell migration was examined using an inverted microscope (Leica, Germany) at 0, 48, and 96 h. The migration distance of the cells was measured using Photoshop (version 2019) software to quantify the wound healing ratio.

2.11 RNA preparation and sequencing

After treatment with the USP8 inhibitor DUB-IN-1 (500 nM) or DMSO as a control for 24 h, total RNAs from LN229 and T98G cells in 6 cm dishes were extracted using Trizol reagent (Thermo Fisher, USA). The integrity of the RNA was detected, and first-strand cDNA and second-strand cDNA were synthesized following fragmentation. The library fragments were purified for polymerase chain reaction, and the library quality was determined after purification.

2.12 Statistics

All experiments were performed at least thrice. Consequences were expressed as mean ± standard error of the mean. A two-tailed Student’s t-test was performed using GraphPad Prism (version 8) software to estimate statistical distinctions between the groups. Statistical significance was set at P < 0.05.

3 Results

3.1 Pharmacological USP8 inhibition suppresses GBM cell proliferation

DUB-IN-1 was reported as a potent USP8 deubiquitinating activity inhibitor, with an IC50 of 0.85 µM for USP8 [13]. Using this inhibitor, we performed MTT assays to measure cell proliferation and observed a dose-dependent effect of USP8 inhibition on cell propagation in LN229, U87MG, and T98G cells (Figure 1a–c). As the U87MG cells appeared to be less sensitive to USP8 inhibition, we selected T98G and LN229 cell lines for subsequent experiments. Consistent with the results from the MTT assays, USP8 inhibition also led to marked reductions in colony formation by both T98G and LN229 cells (Figure 1d). We next examined the expression levels of the proliferation marker Ki-67 in LN229 and T98G cells with or without USP8 inhibition using immunofluorescence assays. As demonstrated in Figure 1e and f, the USP8 inhibitor DUB-IN-1 effectively reduced the percentages of cells with positive Ki-67 staining, suggesting a growth-suppressive influence of USP8 inhibition on these glioma cells. Collectively, these results from various proliferation assays consistently confirmed the inhibitory effects of the USP8 inhibitor DUB-IN-1, on the growth of GMB cells in vitro.

Figure 1 
                  Pharmacological USP8 inhibition suppresses GBM cell proliferation. (a–c) LN229, T98G, and U87MG cells were treated with the USP8 inhibitor DUB-IN-1, and the cell viability was analyzed using the MTT assay. (d) Colony formation assays were performed on cells treated with the USP8 inhibitor DUB-IN-1. (e and f) The representative images of Ki-67 staining assay of T98G and LN229 cells treated with the USP8 inhibitor DUB-IN-1. Scale bar represents 20 µm. *P < 0.05, **P < 0.01 using Student’s t-test; n ≥ 3.
Figure 1

Pharmacological USP8 inhibition suppresses GBM cell proliferation. (a–c) LN229, T98G, and U87MG cells were treated with the USP8 inhibitor DUB-IN-1, and the cell viability was analyzed using the MTT assay. (d) Colony formation assays were performed on cells treated with the USP8 inhibitor DUB-IN-1. (e and f) The representative images of Ki-67 staining assay of T98G and LN229 cells treated with the USP8 inhibitor DUB-IN-1. Scale bar represents 20 µm. *P < 0.05, **P < 0.01 using Student’s t-test; n ≥ 3.

3.2 The migration of GBM cells is attenuated by the USP8 inhibitor DUB-IN-1

The invasiveness of GBM cells presents a challenge for the complete surgical removal of tumor tissues [20,21]. Highly invasive GBM cells often infiltrate peritumoral normal brain tissues, thus making complete removal difficult and ultimately causing tumor recurrence that threatens the lives of the patient [21,22,23]. Therefore, we evaluated the impact of USP8 pharmacological inhibition on the migration of GBM cells. Wound healing assays showed that LN229 and T98G cells treated with the USP8 inhibitor DUB-IN-1 showed significantly decreased migration compared with the DMSO-treated control groups (Figure 2a and b). The effect of USP8 inhibition appeared stronger in LN229 cells, as the suppression of T98G cell migration required a higher concentration of the USP8 inhibitor DUB-IN-1 in T98G cells. We performed Transwell assays using LN229 and T98G cells to study the inhibitory effects of the USP8 inhibitor DUB-IN-1 on GBM cell migration. In accordance with results obtained from the wound healing experiments, the USP8 inhibitor DUB-IN-1 also markedly suppressed cell migration, as revealed through transwell assays with both LN229 and T98G cells (Figure 2c). Therefore, pharmacological USP8 inhibition demonstrated effective antimigration effects on GBM cells in vitro.

Figure 2 
                  The migration of GBM cells is attenuated by DUB-IN-1. (a and b) The representative images of wound healing assay of T98G and LN229 cells treated with the USP8 inhibitor DUB-IN-1. White dotted lines indicate wound edges. Scale bar represents 50 µm. (c) The representative images of Transwell assay of T98G and LN229 cells treated with the USP8 inhibitor DUB-IN-1. Scale bar represents 50 µm. *P < 0.05, **P < 0.01 using Student’s t-test; n = 3.
Figure 2

The migration of GBM cells is attenuated by DUB-IN-1. (a and b) The representative images of wound healing assay of T98G and LN229 cells treated with the USP8 inhibitor DUB-IN-1. White dotted lines indicate wound edges. Scale bar represents 50 µm. (c) The representative images of Transwell assay of T98G and LN229 cells treated with the USP8 inhibitor DUB-IN-1. Scale bar represents 50 µm. *P < 0.05, **P < 0.01 using Student’s t-test; n = 3.

3.3 The USP8 inhibitor DUB-IN-1 decreases GBM stemness and sensitizes GBM cells to IR

GBM exhibits significant intratumoral heterogeneity, forming a range of tumor cell lineages with tumorigenic potential [24]. Accumulating evidence has established that GBM tissues often contain a substantial proportion of tumor stem cell subpopulations [25], which play vital roles in tumor initiation, malignant progression, drug resistance, radioresistance, and tumor recurrence [25,26,27]. Considering previous observations that USPs are involved in the stem cell properties of glioma, such as the association of USP22 with the stemness and tumorigenicity of glioma [28], and EPG5 deubiquitination through USP8 to maintain stemness [29], we hypothesized that the USP8 inhibitor DUB-IN-1 can possibly inhibit the stemness of glioma. To test this hypothesis, we conducted spheroid formation assays to investigate the stemness of GBM cells with or without USP8 inhibition. Cells treated with the USP8 inhibitor DUB-IN-1 showed significantly reduced spheroid size (Figure 3a and b), indicating a dramatic decrease in stemness. Radiotherapy is a major therapeutic modality for clinical management of GBM. To estimate the effect of USP8 inhibition on the radiosensitivity of GBM cells, we performed colony formation assays to evaluate the combined effects of IR and USP8 inhibition. As shown in Figure 3c and d, IR significantly decreased the number of colony clones formed by both LN229 and T98G cells in a dose-dependent manner, and this was significantly sensitized to irradiation-mediated suppresion mediated by the USP8 inhibitor DUB-IN-1.

Figure 3 
                  DUB-IN-1 decreases GBM stemness and sensitizes GBM cells to IR. (a and b) The representative images of spheroid formation assay of T98G and LN229 cells treated with the USP8 inhibitor DUB-IN-1. (c and d) After treatment with the USP8 inhibitor DUB-IN-1, a colony formation assay was performed to measure the proliferation of cells following the IR assay. *P < 0.05, **P < 0.01 using Student’s t-test; n ≥ 3.
Figure 3

DUB-IN-1 decreases GBM stemness and sensitizes GBM cells to IR. (a and b) The representative images of spheroid formation assay of T98G and LN229 cells treated with the USP8 inhibitor DUB-IN-1. (c and d) After treatment with the USP8 inhibitor DUB-IN-1, a colony formation assay was performed to measure the proliferation of cells following the IR assay. *P < 0.05, **P < 0.01 using Student’s t-test; n ≥ 3.

3.4 The USP8 inhibitor DUB-IN-1 leads to decreased AURKA expression

After confirming the inhibitory effects of pharmacological USP8 inhibition on glioma cell growth and stemness, we performed transcriptomic profiling of LN229 and T98G cells with or without USP8 inhibitor DUB-IN-1 treatment to investigate its underlying mechanisms. Differentially expressed genes following USP8 inhibitor DUB-IN-1 treatment in LN229 and T98G cells were analyzed using reactome enrichment. As demonstrated in Figure 4a and b, cell cycle-related functions were common in both LN229 and T98G cells in the top-listed reactome terms. These observations are consistent with our results of decreased cell growth following treatment with the USP8 inhibitor DUB-IN-1 in both GBM cell lines. Next, we investigated the common cell cycle-associated targets of USP8 inhibition in both LN229 and T98G cells. As shown in the Venn diagram in Figure 4c, differentially expressed genes were observed in both GBM cell lines following USP8 inhibition, and the expression of AURKA, which encodes a well-known cell cycle-related AURKA, was among the top 10 most significantly downregulated genes (Table 1).

Figure 4 
                  Transcriptome analysis of GBM cells treated with DUB-IN-1. (a and b) RNA sequencing data (LN229 DMSO vs LN229 500 nM and T98G DMSO vs T98G 500 nM) was analyzed using Metascape with reactome function enrichment analysis and the top 14 functional enrichments were selected, which were visualized using a bioinformatics online tool (www.bioinformatics.com.cn). (c) Venn diagram showing overlapping differentially gene numbers between LN229 vs T98G cells following treatment with the USP8 inhibitor DUB-IN-1 (P < 0.05, log2[fold change] > 1).
Figure 4

Transcriptome analysis of GBM cells treated with DUB-IN-1. (a and b) RNA sequencing data (LN229 DMSO vs LN229 500 nM and T98G DMSO vs T98G 500 nM) was analyzed using Metascape with reactome function enrichment analysis and the top 14 functional enrichments were selected, which were visualized using a bioinformatics online tool (www.bioinformatics.com.cn). (c) Venn diagram showing overlapping differentially gene numbers between LN229 vs T98G cells following treatment with the USP8 inhibitor DUB-IN-1 (P < 0.05, log2[fold change] > 1).

Table 1

Top 10 overlapping down-regulated differentially expressed genes of LN229 and T98G cells

Gene name LN229 T98G
HIST1H2AG −2.189608365 −3.312903097
AC233968.1 −3.58089194 −3.231023759
PI15 −2.046971612 −3.138549889
KIF20A −2.595581918 −2.526225595
PLK1 −1.962584231 −2.001025093
CENPE −1.849243116 −1.83684878
AURKA −1.593150497 −1.675818385
CENPA −1.754749424 −1.550810046
NEK2 −1.552948615 −1.527897074
P2RX7 −3.146447522 −1.525680398

Table showing the top 10 overlapping down-regulated differentially genes set with log2 (fold change).

Previous studies have shown elevated AURKA mRNA expression in glioma [30], and the protein levels of the AURKA were reported to be increased in glioma [31]. Using the Gene Expression Profiling Interactive Analysis (GEPIA) website, we compared the mRNA levels of AURKA in normal and GBM tumor tissues. In accordance with previous findings, AURKA expression was significantly increased in GBM tissues (Figure 5a). Next, we performed Western blotting experiments to validate the reduction of AURKA at the protein level. As shown in Figure 5b and c, AURKA protein expression was sensitive to the USP8 inhibitor DUB-IN-1 in a dose-dependent manner in both LN229 and T98G cells. In conclusion, our outcomes suggest that downregulation of AURKA expression likely contributes to the growth inhibition induced by USP8 pharmacological inhibition.

Figure 5 
                  DUB-IN-1 leads to decreased AURKA expression. (a) Using GEPIA, the expression level of AURKA in tumor (T) tissues was shown to be significantly higher than that in nontumor (N) tissues, *P < 0.05. (b and c) The effects of different concentrations of the inhibitor on AURKA expression. *P < 0.05, **P < 0.01 using Student’s t-test; n ≥ 3.
Figure 5

DUB-IN-1 leads to decreased AURKA expression. (a) Using GEPIA, the expression level of AURKA in tumor (T) tissues was shown to be significantly higher than that in nontumor (N) tissues, *P < 0.05. (b and c) The effects of different concentrations of the inhibitor on AURKA expression. *P < 0.05, **P < 0.01 using Student’s t-test; n ≥ 3.

4 Discussion

Glioma typically originates from glial or precursor cells and accounts for approximately 30% of brain tumors as well as approximately 80% of malignant primary brain tumors [32], with more than 10,000 cases diagnosed yearly in the United States [33]. The survival time of patients with GBM has not been dramatically improved with current treatments. Therefore, further investigation of GBM tumorigenesis is necessary to identify high-quality biomarkers and potential therapeutic targets.

USP8 is a member of the USP family of DUBs and is closely associated with tumorigenesis and drug resistance. USP8 has also been proposed as a prognostic factor for breast cancer [34]. Previous studies have revealed various functions of USP8 in various tumors [12,35,36]. The current study focused on its role in GBM cell growth, migration, and stemness. Members of the USP family have been reported to regulate GBM tumorigenesis [37,38,39]. USP15 promotes tumor cell invasion and proliferation in GBM [40]. Regarding USP8, its tumor-promoting functions have been reported in several cancer types, and its inhibition reduces the invasion of cholangiocarcinoma cells [41]. DUB-IN-1 treatment inhibited esophageal squamous cell carcinoma cell growth and induce G2/M cell cycle arrest, apoptosis, and autophagy through DNA damage-induced p53 activation [42]. However, there are few studies on USP8 in GBM. Therefore, we studied the effect of DUB-IN-1 on GBM cells. U87MG cells were found to have a lower sensitivity to DUB-IN-1 (Figure 1a–c). In the cell viability assay, the inhibition rate of U87MG cells was lower than that of the previous two cell types when the DUB-IN-1 dose was thrice applied to T98G and LN229 cells. Therefore, LN229 and T98G cells were selected for the follow-up study. In these two cell lines, DUB-IN-1 significantly inhibited the formation of cell colonies (Figure 1d). In addition, DUB-IN-1 effectively reduced the percentage of Ki-67-positive cells in LN229 and T98G cells, as shown using an immunofluorescence assay (Figure 1e and f). In summary, DUB-IN-1 inhibited the growth of GBM cells. Highly invasive GBM cells often infiltrate the normal brain tissue around the tumor [21], making it difficult to completely remove the tumor tissue [23] and ultimately leading to tumor recurrence [21,22]. Studies have shown that USP8 can promote migration and invasion in tumors. In this study, the effects of DUB-IN-1 on GBM LN229 and T98G cell migration were evaluated using wound healing and Transwell assays. The results showed that DUB-IN-1 effectively inhibited the migration and invasion of LN229 and T98G cells (Figure 2). From a pharmacological perspective, USP8 inhibition had an effective anti-migration effect on GBM cells in vitro. It is noteworthy that GBM stemness is a major cause of relapse and treatment resistance [43,44]. The involvement of deubiquitylases in maintaining cancer cell stemness has been previously reported [45,46]. The inhibition of USP1 can inhibit the growth of GBM cells by inhibiting stem cell renewal and radioresistance [47]. SMO enhances the radiation resistance of GBM cells by promoting the transcription of USP3 and activating Claspin-dependent ATR-Chk1 signaling [48]. Our study showed that the stemness of LN229 and T98G cells was significantly attenuated by the USP8 inhibitor DUB-IN-1, as revealed by the results of the spheroid formation assay (Figure 3a and b). In addition, we evaluated the sensitivity of LN229 and T98G cells treated with DUB-IN-1 to IR using a colony formation assay. The experimental results showed that DUB-IN-1 treatment effectively sensitized LN229 and T98G cells to IR (Figure 3c and d).

To investigate the potential mechanism by which DUB-IN-1 inhibits the growth, migration, and stemness of LN229 and T98G cells, transcriptome analysis was performed on LN229 and T98G cells, and differentially expressed genes in LN229 and T98G cells were analyzed using reactome functional enrichment. The results showed that the first several pathways are related to cell cycle function. Based on the Venn diagram, differentially expressed genes were found in both LN229 and T98G cells after treatment with DUB-IN-1 (Figure 4c), and the common differentially expressed genes were analyzed. AURKA, a gene associated with the cell cycle, was among the 10 most significantly downregulated genes, and the transcriptome results showed that AURKA expression decreased after the use of the inhibitor, which was consistent with our previous findings. DUB-IN-1 treatment has been reported to induce G2/M cell cycle arrest by upregulating the protein level of p21 and trigger apoptosis by modulating p53 target proteins, including Bax, Noxa, and Puma [42]. AURKA may act as a potential mechanism through which USP8 inhibitors inhibit the growth, migration, and stemness of LN229 and T98G cells.

AURKA is located on chromosome 20q13.2 and plays a crucial role in the control of mitotic progression. The AURKA oncogene is amplified in various tumors, including glioma [31]. It has been reported that the expression of AURKA mRNA is increased in glioma [30], which is consistent with our results from bioinformatic analysis (Figure 5a). Interestingly, the USP8 inhibitor DUB-IN-1 decreased AURKA mRNA expression and also inhibited AURKA expression in a dose-dependent manner (Figure 5b and c). It has been shown that the AURKA activity is vital to promote colony formation and tumor growth [49]. In addition, inhibition of AURKA was reported to improve the efficacy of radiotherapy [50]. Therefore, the reduction in AURKA expression induced by pharmacological USP8 inhibition is likely a significant factor in GBM cell suppression. However, this study lacks in vivo analysis to verify the in vitro studies, and other research methods are required for further study in the future [14,51,52,53,54].

In summary, by demonstrating the effectiveness of pharmacological USP8 inhibition in suppressing GBM cell growth, migration, and stemness, as well as in promoting the sensitivity of GBM cells to radiotherapy, our findings suggest USP8 as a potential therapeutic target for the treatment of GBM, warranting further investigation.


# Contributed equally.

tel: +86-17709875990, +0411-84671291-5331
tel: +86-17709875987, +0411-84671291-5331

  1. Funding information: This work was supported by the National Natural Science Foundation of China (Grant no. 81801228 to HM) and Dalian Key Field Innovation Team Project (Grant no. 2021RT14).

  2. Author contributions: Y.L. and Z.C.H. designed the experiments and carried them out. D.Y. and F.Q.W. optimized the experimental ideas; C.G.Z., Y.Z., and Y.Q.Z. helped with data analysis. H.M. and H.Y.L. provided experimental ideas and financial support. The authors applied the SDC approach for the sequence of authors.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Bonavia R, Inda MM, Cavenee WK, Furnari FB. Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 2011;71:4055–60.10.1158/0008-5472.CAN-11-0153Search in Google Scholar PubMed PubMed Central

[2] Tanaka S, Louis DN, Curry WT, Batchelor TT, Dietrich J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol. 2013;10:14–26.10.1038/nrclinonc.2012.204Search in Google Scholar PubMed

[3] Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol. 2014;16(Suppl 4):iv1–63.10.1093/neuonc/nou223Search in Google Scholar PubMed PubMed Central

[4] Xu H, Zhang B, Yang Y, Li Z, Zhao P, Wu W, et al. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis. J Cell Mol Med. 2020;24:6362–72.10.1111/jcmm.15280Search in Google Scholar PubMed PubMed Central

[5] Adams J. The proteasome: a suitable antineoplastic target. Nat Rev Cancer. 2004;4:349–60.10.1038/nrc1361Search in Google Scholar PubMed

[6] Bota DA, Alexandru D, Keir ST, Bigner D, Vredenburgh J, Friedman HS. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells’ VEGF production and angiogenesis. J Neurosurg. 2013;119:1415–23.10.3171/2013.7.JNS1323Search in Google Scholar PubMed PubMed Central

[7] Komander D, Clague MJ, Urbé S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10:550–63.10.1038/nrm2731Search in Google Scholar PubMed

[8] Lill JR, Wertz IE. Toward understanding ubiquitin-modifying enzymes: from pharmacological targeting to proteomics. Trends Pharmacol Sci. 2014;35:187–207.10.1016/j.tips.2014.01.005Search in Google Scholar PubMed

[9] Hochstrasser M. Ubiquitin and intracellular protein degradation. Curr Opin Cell Biol. 1992;4:1024–31.10.1016/0955-0674(92)90135-YSearch in Google Scholar PubMed

[10] Naviglio S, Mattecucci C, Matoskova B, Nagase T, Nomura N, Di Fiore PP, et al. UBPY: a growth-regulated human ubiquitin isopeptidase. EMBO J. 1998;17:3241–50.10.1093/emboj/17.12.3241Search in Google Scholar PubMed PubMed Central

[11] Shin S, Kim K, Kim HR, Ylaya K, Do SI, Hewitt SM, et al. Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer. Cell Death Differ. 2020;27:1341–54.10.1038/s41418-019-0419-1Search in Google Scholar PubMed PubMed Central

[12] Panner A, Crane CA, Weng C, Feletti A, Fang S, Parsa AT, et al. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme. Cancer Res. 2010;70:5046–53.10.1158/0008-5472.CAN-09-3979Search in Google Scholar PubMed PubMed Central

[13] Colombo M, Vallese S, Peretto I, Jacq X, Rain JC, Colland F, et al. Synthesis and biological evaluation of 9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes. ChemMedChem. 2010;5:552–8.10.1002/cmdc.200900409Search in Google Scholar PubMed

[14] Sun J, Shen D, Gao Y, Zheng Y, Zhao L, Maa M, et al. Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation. Onco Targets Ther. 2020;13:7973–84.10.2147/OTT.S264108Search in Google Scholar PubMed PubMed Central

[15] Vuletic A, Konjevic G, Milanovic D, Ruzdijic S, Jurisic V. Antiproliferative effect of 13-cis-retinoic acid is associated with granulocyte differentiation and decrease in cyclin B1 and Bcl-2 protein levels in G0/G1 arrested HL-60 cells. Pathol Oncol Res. 2010;16:393–401.10.1007/s12253-009-9241-2Search in Google Scholar PubMed

[16] Liu S, Wang T, Shi Y, Bai L, Wang S, Guo D, et al. USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis. Cell Death Differ. 2021;28:2482–98.10.1038/s41418-021-00763-6Search in Google Scholar PubMed PubMed Central

[17] Zhang J, Liu S, Li Q, Shi Y, Wu Y, Liu F, et al. The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer. Cell Death Differ. 2020;27:2710–25.10.1038/s41418-020-0538-8Search in Google Scholar PubMed PubMed Central

[18] Wu Y, Zhang Y, Wang D, Zhang Y, Zhang J, Zhang Y, et al. USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress. Cell Death Dis. 2020;11:796.10.1038/s41419-020-03008-5Search in Google Scholar PubMed PubMed Central

[19] Amin A, Farrukh A, Murali C, Soleimani A, Praz F, Graziani G, et al. Saffron and its major ingredients’ effect on colon cancer cells with mismatch repair deficiency and microsatellite instability. Molecules. 2021;26:3855.10.3390/molecules26133855Search in Google Scholar PubMed PubMed Central

[20] Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003;21:1624–36.10.1200/JCO.2003.05.063Search in Google Scholar PubMed

[21] Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21:2683–710.10.1101/gad.1596707Search in Google Scholar PubMed

[22] Malzkorn B, Reifenberger G. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016. Curr Opin Oncol. 2016;28:494–501.10.1097/CCO.0000000000000327Search in Google Scholar PubMed

[23] Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001;15:1311–33.10.1101/gad.891601Search in Google Scholar PubMed

[24] Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell. 2010;17:362–75.10.1016/j.ccr.2009.12.049Search in Google Scholar PubMed

[25] Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401.10.1038/nature03128Search in Google Scholar PubMed

[26] Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756–60.10.1038/nature05236Search in Google Scholar PubMed

[27] Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, et al. Analysis of gene expression and chemoresistance of CD133 + cancer stem cells in glioblastoma. Mol Cancer. 2006;5:67.10.1186/1476-4598-5-67Search in Google Scholar PubMed PubMed Central

[28] Qiu GZ, Mao XY, Ma Y, Gao XC, Wang Z, Jin MZ, et al. Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization. Cancer Sci. 2018;109:2199–210.10.1111/cas.13646Search in Google Scholar PubMed PubMed Central

[29] Gu H, Shi X, Liu C, Wang C, Sui N, Zhao Y, et al. USP8 maintains embryonic stem cell stemness via deubiquitination of EPG5. Nat Commun. 2019;10:1465.10.1038/s41467-019-09430-4Search in Google Scholar PubMed PubMed Central

[30] Loh JK, Lieu AS, Chou CH, Lin FY, Wu CH, Howng SL, et al. Differential expression of centrosomal proteins at different stages of human glioma. BMC Cancer. 2010;10:268.10.1186/1471-2407-10-268Search in Google Scholar PubMed PubMed Central

[31] Klein A, Reichardt W, Jung V, Zang KD, Meese E, Urbschat S. Overexpression and amplification of STK15 in human gliomas. Int J Oncol. 2004;25:1789–94.10.3892/ijo.25.6.1789Search in Google Scholar

[32] Jain KK. A Critical Overview of Targeted Therapies for Glioblastoma. Front Oncol. 2018;8:419.10.3389/fonc.2018.00419Search in Google Scholar PubMed PubMed Central

[33] Reardon DA, Mitchell DA. The development of dendritic cell vaccine-based immunotherapies for glioblastoma. Semin Immunopathol. 2017;39:225–39.10.1007/s00281-016-0616-7Search in Google Scholar PubMed

[34] Qiu H, Kong J, Cheng Y, Li G. The expression of ubiquitin-specific peptidase 8 and its prognostic role in patients with breast cancer. J Cell Biochem. 2018;119:10051–8.10.1002/jcb.27337Search in Google Scholar PubMed

[35] Yan M, Zhao C, Wei N, Wu X, Cui J, Xing Y. High expression of Ubiquitin-Specific Protease 8 (USP8) is associated with poor prognosis in patients with cervical squamous cell carcinoma. Med Sci Monit. 2018;24:4934–43.10.12659/MSM.909235Search in Google Scholar PubMed PubMed Central

[36] Duan B, Wang C, Liu Z, Yang X. USP8 is a novel therapeutic target in melanoma through regulating receptor tyrosine kinase levels. Cancer Manag Res. 2021;13:4181–9.10.2147/CMAR.S300195Search in Google Scholar PubMed PubMed Central

[37] Wang CL, Wang JY, Liu ZY, Ma XM, Wang XW, Jin H, et al. Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma. Carcinogenesis. 2014;35:1500–9.10.1093/carcin/bgu015Search in Google Scholar PubMed

[38] Liang J, Zhang XL, Li S, Xie S, Wang WF, Yu RT. Ubiquitin-specific protease 22 promotes the proliferation, migration and invasion of glioma cells. Cancer Biomark. 2018;23:381–9.10.3233/CBM-181413Search in Google Scholar PubMed

[39] Fan L, Chen Z, Wu X, Cai X, Feng S, Lu J, et al. Ubiquitin-specific protease 3 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via stabilizing snail. Mol Cancer Res. 2019;17:1975–84.10.1158/1541-7786.MCR-19-0197Search in Google Scholar PubMed

[40] Eichhorn PJ, Rodón L, Gonzàlez-Juncà A, Dirac A, Gili M, Martínez-Sáez E, et al. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat Med. 2012;18:429–35.10.1038/nm.2619Search in Google Scholar PubMed

[41] Jing X, Chen Y, Chen Y, Shi G, Lv S, Cheng N, et al. Down-regulation of USP8 inhibits cholangiocarcinoma cell proliferation and invasion. Cancer Manag Res. 2020;12:2185–94.10.2147/CMAR.S234586Search in Google Scholar PubMed PubMed Central

[42] Sha B, Sun Y, Zhao S, Li M, Huang W, Li Z, et al. USP8 inhibitor-induced DNA damage activates cell cycle arrest, apoptosis, and autophagy in esophageal squamous cell carcinoma. Cell Biol Toxicol. 2022:1–22.10.1007/s10565-021-09686-xSearch in Google Scholar PubMed

[43] Hu B, Wang Q, Wang YA, Hua S, Sauvé CG, Ong D, et al. Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth. Cell. 2016;167:1281–95.10.1016/j.cell.2016.10.039Search in Google Scholar PubMed PubMed Central

[44] Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29:1203–17.10.1101/gad.261982.115Search in Google Scholar PubMed PubMed Central

[45] Qiu GZ, Liu Q, Wang XG, Xu GZ, Zhao T, Lou MQ. Hypoxia-induced USP22-BMI1 axis promotes the stemness and malignancy of glioma stem cells via regulation of HIF-1α. Life Sci. 2020;247:117438.10.1016/j.lfs.2020.117438Search in Google Scholar PubMed

[46] Cheng CD, Dong YF, Niu WX, Niu CS. HAUSP promoted the growth of glioma cells in vitro and in vivo via stabilizing NANOG. Pathol Res Pract. 2020;216:152883.10.1016/j.prp.2020.152883Search in Google Scholar PubMed

[47] Lee JK, Chang N, Yoon Y, Yang H, Cho H, Kim E, et al. USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance. Neuro Oncol. 2016;18:37–47.10.1093/neuonc/nov091Search in Google Scholar PubMed PubMed Central

[48] Tu Y, Chen Z, Zhao P, Sun G, Bao Z, Chao H, et al. Smoothened promotes glioblastoma radiation resistance via activating USP3-mediated claspin deubiquitination. Clin Cancer Res. 2020;26:1749–62.10.1158/1078-0432.CCR-19-1515Search in Google Scholar PubMed

[49] Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1998;17:3052–65.10.1093/emboj/17.11.3052Search in Google Scholar PubMed PubMed Central

[50] Liu F, Zhang Y, Dong Y, Ning P, Zhang Y, Sun H, et al. Knockdown of AURKA sensitizes the efficacy of radiation in human colorectal cancer. Life Sci. 2021;271:119148.10.1016/j.lfs.2021.119148Search in Google Scholar PubMed

[51] Sun J, Shen D, Zheng Y, Ren H, Liu H, Chen X, et al. USP8 inhibitor suppresses HER-2 positive gastric cancer cell proliferation and metastasis via the PI3K/AKT signaling pathway. Onco Targets Ther. 2020;13:9941–52.10.2147/OTT.S271496Search in Google Scholar PubMed PubMed Central

[52] Amin A, Lotfy M, Mahmoud-Ghoneim D, Adeghate E, Al-Akhras MA, Al-Saadi M, et al. Pancreas-protective effects of chlorella in STZ-induced diabetic animal model: Insights into the mechanism. J Diabetes Mellitus. 2011;1:36–45.10.4236/jdm.2011.13006Search in Google Scholar

[53] Al-Shamsi M, Amin A, Adeghate E. Vitamin E ameliorates some biochemical parameters in normal and diabetic rats. Ann N Y Acad Sci. 2006;1084:411–31.10.1196/annals.1372.033Search in Google Scholar PubMed

[54] Al Shamsi MS, Amin A, Adeghate E. Beneficial effect of vitamin E on the metabolic parameters of diabetic rats. Mol Cell Biochem. 2004;261:35–42.10.1023/B:MCBI.0000028735.79172.9bSearch in Google Scholar PubMed

Received: 2022-11-02
Revised: 2022-12-08
Accepted: 2023-01-04
Published Online: 2023-02-09

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0562/html
Scroll to top button